Table 2.
Receptors | Matching Ligands | Theranostic Agents | Delivery Vehicles | Ref. |
---|---|---|---|---|
AFP | Antibody | Gd ion, paclitaxel | Polymeric micelle | [43] |
USPION | Surface modified USPION | [44,45] | ||
Cy7 fluorescent dye, Fe3O4 | Liposome | [46] | ||
GPC-3 | Peptide | Gd ion | WS2-PEG | [47] |
FeSe2 | FeSe2-PEG | [48] | ||
Fe3O4, Au, Cy5.5 | Fe3O4 core/Au shell nanocomplex | [49] | ||
USPION | Surface modified USPION | [50] | ||
Aptamer | USPION | Surface modified USPION | [51] | |
Antibody | Fe3O4 | Semiconducting polymers | [52] | |
SPION, sorafenib | Micelle | [53] | ||
SPION | Surface modified SPION | [54] | ||
PBNP | PBNP | [55] | ||
Folate Receptor | Folic acid | SiRNA, SPION | Polymeric micelle | [56] |
Gd ion | Porphyrin metal-organic frameworks | [57] | ||
Gd ion | Phase transition nanodroplets | [58] | ||
Triptolide | Folate modified triptolide | [59] | ||
Fe3O4, arsenic trioxide | Mesoporous silica nanoparticles | [60] | ||
SPION, sorafenib | PLGA-PEG | [61] | ||
SiRNA, SPION | Amylose | [62] | ||
magneto-gold nanoparticle | Surface modified magneto-gold nanoparticle | [63] | ||
Magnetite nanoparticle | polydopamine-coated magnetite nanoparticles | [64] | ||
CuFeSe2 | CuFeSe2-PEG | [65] | ||
VEGF/VEGFR | Peptide | Gd ion | VEGF-Gd chelates | [66] |
Antibody | Gd ion | Polymeric nanoparticle | [67] | |
SPION | Polymeric micelle | [68] | ||
Gd ion | Biotin-PLL-DTPA | [69] | ||
Sorafenib, Gd ion | Multiblock polymer | [70] | ||
Integrin | Peptide | Gd ion | Peptide | [71] |
Fe3O4 | Fe3O4 nanoparticles | [72,73] | ||
Gadolinium arsenate | Gadolinium arsenate nanoparticles | [74] | ||
SiRNA, SPION | Polymeric nanoparticle | [75] | ||
Fe3O4, doxorubicin | Polylysine dendrimer | [76] | ||
Gd ion, SPION | SPION nanoparticles | [77] | ||
NIRF probe, SPION | SPION nanoparticles | [78] | ||
Endoglin | Aptamer | Cy5.5, Fe3O4 | Magnetic-fluorescent endoglin aptamer nanoprobe | [79] |
Gd ion, NIR fluorophore | Dendrimer | [80] | ||
Fe3O4 | Carboxymethyl chitosan nanoparticles | [81] | ||
ASGP-R | Galactose | Fe3O4, NIRF probe | Lipid shell | [82] |
Lactobionic acid | Au nanoparticles, ICG, Gd (Ⅲ)-DOTA | Au nanoparticles @ polydopamine | [83] | |
MicroRNA-99a | PLGA nanoparticles | [84] | ||
Manganese ferrite nanoparticle | Manganese ferrite nanoparticles | [85] | ||
CD44 | Hyaluronic acid | Au nanoparticles, Mn ion | Dendrimer | [86] |
Gd ion | Hyaluronic acid -DTPA-Gd | [87] | ||
Doxorubicin, SPION | Copolymers | [88] | ||
Antibody | Nd3+ | Upconversion nanoparticle | [89] | |
CD90 | Antibody | 17-AAG, thermosensitive magnetoliposomes | Thermosensitive magnetoliposomes | [90] |
Fe3O4 | Thermosensitive magnetoliposomes | [91] | ||
EGFR | Peptide | USPION | Surface modified USPION | [92] |
SPION | Chitosan oligosaccharide micelle | [93] | ||
E-selectin | Salic acid | Reporter gene, SPION | Mesoporous polydopamine | [94] |
Gd-CuS nanoparticle, Doxorubicin | Polymeric micelles | [95] |
Abbreviations: AFP, alpha-fetoprotein; ASGP-R, asialoglycoprotein receptor; DTPA, diethylene triamine pentacetate acid; DOTA, 1,4,7,10-tetraazacyclododecane-N,N′,N,N′-tetraacetic acid; EGFR, epidermal growth factor receptor; GPC-3, glypican-3; ICG, indocyanine green; NIRF, near-infrared fluorescence; PEG, polyethylene glycol; PLL, poly-l-lysine; PLGA, poly(lactic-co-glycolic acid); PBNP, Prussian blue nanoparticle; SPION, superparamagnetic iron oxide nanoparticle; USPION, ultra-small superparamagnetic iron oxide nanoparticle; VEGF, vascular endothelial growth factor; VEGFR, vascular endothelial growth factor receptor; 17-AAG, 17-allylamino-17-demethoxygeldanamycin.